SPICKSCHEN THORLEF 4
4 · Clovis Oncology, Inc. · Filed Apr 9, 2018
Insider Transaction Report
Form 4
SPICKSCHEN THORLEF
Director
Transactions
- Sale
Common Stock
2018-04-09$60.02/sh−4,500$270,090→ 7,618 total
Footnotes (2)
- [F1]This transaction was executed in multiple trades at prices ranging from $60.00 to $60.16. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 8, 2017.